Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5457862 [patent_doc_number] => 20090258014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'COMBINATION OF HGF INHIBITOR AND EGF INHIBITOR TO TREAT CANCER' [patent_app_type] => utility [patent_app_number] => 12/421556 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10185 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258014.pdf [firstpage_image] =>[orig_patent_app_number] => 12421556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421556
COMBINATION OF HGF INHIBITOR AND EGF INHIBITOR TO TREAT CANCER Apr 8, 2009 Abandoned
Array ( [id] => 4629115 [patent_doc_number] => 08007997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Methods and compositions for inhibiting the growth of hematopoietic malignant cells' [patent_app_type] => utility [patent_app_number] => 12/420676 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 44 [patent_no_of_words] => 17900 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007997.pdf [firstpage_image] =>[orig_patent_app_number] => 12420676 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/420676
Methods and compositions for inhibiting the growth of hematopoietic malignant cells Apr 7, 2009 Issued
Array ( [id] => 6371309 [patent_doc_number] => 20100075342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Biomarker for ovarian cancer CTAP3-related proteins' [patent_app_type] => utility [patent_app_number] => 12/384246 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16192 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075342.pdf [firstpage_image] =>[orig_patent_app_number] => 12384246 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/384246
Biomarker for ovarian cancer CTAP3-related proteins Apr 1, 2009 Abandoned
Array ( [id] => 5928921 [patent_doc_number] => 20110038880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PARASPORIN-1 RECEPTOR AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/935513 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9685 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038880.pdf [firstpage_image] =>[orig_patent_app_number] => 12935513 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/935513
PARASPORIN-1 RECEPTOR AND USE THEREOF Mar 29, 2009 Abandoned
Array ( [id] => 5533525 [patent_doc_number] => 20090233313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'QUANTIFICATION AND AFFINITY CHARACTERIZATION OF ANTIBODIES FOR THE DIAGNOSIS OF DISEASE USING OPTICAL DIFFRACTION' [patent_app_type] => utility [patent_app_number] => 12/402009 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5970 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233313.pdf [firstpage_image] =>[orig_patent_app_number] => 12402009 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/402009
QUANTIFICATION AND AFFINITY CHARACTERIZATION OF ANTIBODIES FOR THE DIAGNOSIS OF DISEASE USING OPTICAL DIFFRACTION Mar 10, 2009 Abandoned
Array ( [id] => 6220592 [patent_doc_number] => 20100055687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571' [patent_app_type] => utility [patent_app_number] => 12/381448 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36838 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055687.pdf [firstpage_image] =>[orig_patent_app_number] => 12381448 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/381448
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571 Mar 10, 2009 Issued
Array ( [id] => 6537848 [patent_doc_number] => 20100221709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'METHODS FOR IDENTIFYING AGENTS THAT MODULATE APOPTOSIS IN CELLS THAT OVER-EXPRESS A BCL-2 FAMILY MEMBER PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/400717 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31806 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221709.pdf [firstpage_image] =>[orig_patent_app_number] => 12400717 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/400717
METHODS FOR IDENTIFYING AGENTS THAT MODULATE APOPTOSIS IN CELLS THAT OVER-EXPRESS A BCL-2 FAMILY MEMBER PROTEIN Mar 8, 2009 Abandoned
Array ( [id] => 9060100 [patent_doc_number] => 08546535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Lytic domain fusion constructs and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 12/398965 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 29389 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12398965 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/398965
Lytic domain fusion constructs and methods of making and using same Mar 4, 2009 Issued
Array ( [id] => 5534072 [patent_doc_number] => 20090233860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/398958 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 28873 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233860.pdf [firstpage_image] =>[orig_patent_app_number] => 12398958 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/398958
LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME Mar 4, 2009 Abandoned
Array ( [id] => 8270507 [patent_doc_number] => 08212010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Sphingosine 1-phosphate antagonism' [patent_app_type] => utility [patent_app_number] => 12/391664 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16812 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12391664 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/391664
Sphingosine 1-phosphate antagonism Feb 23, 2009 Issued
Array ( [id] => 5473615 [patent_doc_number] => 20090246781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Method for early determination of recurrence after therapy for prostate cancer' [patent_app_type] => utility [patent_app_number] => 12/378965 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18732 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246781.pdf [firstpage_image] =>[orig_patent_app_number] => 12378965 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/378965
Method for early determination of recurrence after therapy for prostate cancer Feb 18, 2009 Abandoned
Array ( [id] => 6031004 [patent_doc_number] => 20110081350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions' [patent_app_type] => utility [patent_app_number] => 12/867911 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10166 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081350.pdf [firstpage_image] =>[orig_patent_app_number] => 12867911 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/867911
Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions Feb 17, 2009 Issued
Array ( [id] => 10857770 [patent_doc_number] => 08883972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification' [patent_app_type] => utility [patent_app_number] => 12/379084 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9231 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12379084 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/379084
High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification Feb 11, 2009 Issued
Array ( [id] => 5485754 [patent_doc_number] => 20090275519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Therapeutic peptidomimetic macrocycles' [patent_app_type] => utility [patent_app_number] => 12/378047 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 34626 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275519.pdf [firstpage_image] =>[orig_patent_app_number] => 12378047 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/378047
Therapeutic peptidomimetic macrocycles Feb 8, 2009 Abandoned
Array ( [id] => 6588913 [patent_doc_number] => 20100062003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BASED ON THE ROLE OF THE CXCR-4 GENE IN TUMORIGENESIS' [patent_app_type] => utility [patent_app_number] => 12/367308 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 31041 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062003.pdf [firstpage_image] =>[orig_patent_app_number] => 12367308 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/367308
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis Feb 5, 2009 Issued
Array ( [id] => 5485843 [patent_doc_number] => 20090275608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Methods of diagnosing and treating parp-mediated diseases' [patent_app_type] => utility [patent_app_number] => 12/322551 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 77775 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275608.pdf [firstpage_image] =>[orig_patent_app_number] => 12322551 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/322551
Methods of diagnosing and treating parp-mediated diseases Feb 3, 2009 Abandoned
Array ( [id] => 6024175 [patent_doc_number] => 20110052501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS' [patent_app_type] => utility [patent_app_number] => 12/863189 [patent_app_country] => US [patent_app_date] => 2009-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 99 [patent_no_of_words] => 129324 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052501.pdf [firstpage_image] =>[orig_patent_app_number] => 12863189 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/863189
POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS Jan 31, 2009 Abandoned
Array ( [id] => 6196053 [patent_doc_number] => 20110027811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'ASSAY SYSTEM FOR THE ASSESSMENT OF ONCOGENICITY, TUMOR PROGRESSION, AND TREATMENT EFFICACY' [patent_app_type] => utility [patent_app_number] => 12/864185 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4578 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027811.pdf [firstpage_image] =>[orig_patent_app_number] => 12864185 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/864185
Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy Jan 25, 2009 Issued
Array ( [id] => 8543607 [patent_doc_number] => 08318899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Lytic domain fusion constructs and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 12/359906 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 29294 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12359906 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/359906
Lytic domain fusion constructs and methods of making and using same Jan 25, 2009 Issued
Array ( [id] => 5434984 [patent_doc_number] => 20090169570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS AND AGENTS FOR IMPROVING TARGETING OF CD138 EXPRESSING TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 12/342815 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 29826 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169570.pdf [firstpage_image] =>[orig_patent_app_number] => 12342815 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/342815
Methods and agents for improving targeting of CD138 expressing tumor cells Dec 22, 2008 Issued
Menu